MERCK PUBLISHES 2016/2017
CORPORATE RESPONSIBILITY REPORT
Inventing for life to discover sustainable solutions for a healthier tomorrow.

For more than a century, our company has been inventing medicines and vaccines for the world’s most challenging diseases. Our 2016/2017 Corporate Responsibility Report illustrates our ongoing quest to save and improve lives through invention while also contributing to a healthier and more hopeful world.

READ THE REPORT

Merck's corporate responsibility approach has four focus areas:

Access to Health

293 million people reached through our major programs and partnerships

Employees

In 2016, 51 percent of our new hires were women and 37 percent were from under-represented groups in the United States

Environmental Sustainability

We established 12 new environmental sustainability goals to manage the impact of our operations, supply chain, products and packaging

Ethics and Transparency

Industry-leading commitment to disclose information about our drug pricing

We’re pleased to report on our progress toward improving the health and well-being of people around the world and our ongoing commitments to our stakeholders, as detailed in the 2016/2017 Corporate Responsibility Report. Highlights include:

Addressing 88 percent of the top 20 global burdens of disease with our products and pipeline.

Launching new initiatives to improve the health of underserved communities with chronic diseases and saving the lives of more women through Merck for Mothers, our global initiative to end preventable maternal deaths

Earning recognition from the U.S. Environmental Protection Agency for utilizing green chemistry design principles, reducing raw material costs by 93 percent and water usage by 90 percent

Increasing our business with diverse suppliers by nearly 60 percent, totaling more than $1 billion in 2016

Expanding the reach of our Animal Health business through new products and educational initiatives

Building an environment where diversity and inclusion is woven into the fabric of our culture

R&D Breakthroughs

Our R&D efforts prioritize promising research and clinical development that represent breakthrough science and target many of the worlds’ most urgent global health challenges.

We continue to push the boundaries of science with the hope and expectation that our innovative solutions will lead to better health for generations to come. That same commitment to overcoming the world’s greatest health challenges extends to how we operate as a responsible company -- building a sustainable business that contributes to a healthier world.

- Kenneth C. Frazier, chairman and chief executive officer, Merck